Inflammatory Bowel Disease News and Research

RSS
Inflammatory bowel disease (IBD) is an ongoing or chronic health problem that causes inflammation and swelling in the digestive tract. The irritation causes bleeding sores called ulcers to form along the digestive tract. This in turn can cause crampy, abdominal pain and severe bloody diarrhea.

There are two main types of inflammatory bowel disease: ulcerative colitis (UC) and Crohn's disease (CD). The diseases are very similar. In fact, doctors often have a hard time figuring out which type of IBD a person has. The main difference between UC and CD is the area of the digestive tract they affect. CD can occur along the entire digestive tract and spread deep into the bowel wall. In contrast, UC usually only affects the top layer of the large intestine (colon) and rectum. Medicine can control the symptoms of IBD in most women. But for people who have severe IBD, surgery is sometimes needed. Over the course of a person's life, the symptoms of IBD often come and go. With close monitoring and medicines, most people with IBD lead full and active lives.
21 new genes found for Crohn's disease

21 new genes found for Crohn's disease

Potential new way to prevent graft-versus-host disease

Potential new way to prevent graft-versus-host disease

Gastroenteritis outbreak in South Australia claims another life

Gastroenteritis outbreak in South Australia claims another life

Australian scientists discover digestive super bugs with potential to improve human health

Australian scientists discover digestive super bugs with potential to improve human health

Three sequencing companies join 1000 Genomes Project

Three sequencing companies join 1000 Genomes Project

Bacterial communities inside us can provide better understanding of health and disease

Bacterial communities inside us can provide better understanding of health and disease

New approach to treating autoimmune disease offered by Weizmann scientists

New approach to treating autoimmune disease offered by Weizmann scientists

New genetic mutations involved in inflammatory intestinal disorders discovered

New genetic mutations involved in inflammatory intestinal disorders discovered

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s

Tuberculosis not the only risk from new immunological drugs

Tuberculosis not the only risk from new immunological drugs

Role of genetic components of dendritic cells could lead to more effective drugs

Role of genetic components of dendritic cells could lead to more effective drugs

FDA approves Cimzia as treatment for Crohn's disease

FDA approves Cimzia as treatment for Crohn's disease

Boys are twice as likely as girls in the U.S. and Asia to receive growth hormone

Boys are twice as likely as girls in the U.S. and Asia to receive growth hormone

Takeda to acquire Millennium for $8.8 billion

Takeda to acquire Millennium for $8.8 billion

Omega-3 fatty acids ineffective for managing Crohn's disease

Omega-3 fatty acids ineffective for managing Crohn's disease

Study identifies infection risks for patients with inflammatory bowel disease

Study identifies infection risks for patients with inflammatory bowel disease

Potential new genetic markers for Crohn's disease

Potential new genetic markers for Crohn's disease

The effect of melatonin on colitis

The effect of melatonin on colitis

How do infections and toxins launch a cell's self-destruct and alarm system?

How do infections and toxins launch a cell's self-destruct and alarm system?

Colon cancer treatment, symptoms, clinical trials

Colon cancer treatment, symptoms, clinical trials